Pharma Pulse 10/9/24: Unclear Product Labeling, What Drug Rates Are Reported in Price Transparency Data? & more

Challenges of Unclear Product Labeling on Patient Outcomes

Drug labeling has become a key issue in the pharmaceutical industry. Mislabeling has frequently led to providers prescribing the wrong medications to their patients. In an interview with Pharm Exec, Laura Johnson, senior director, sales, life sciences, Loftware, discussed key challenges of drug labeling, ensuring that labels are easily understood, unclear labeling, and the role of digital passports.

What Drug Rates Are Reported in Price Transparency Data?

It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.

Cyber Providers See Strong Demand, but Few Feel Confident Enough to List

Funding rounds are up and customers want their products, but cyber companies are still shying away from IPOs.

Kindeva Drug Delivery Completes Registration Batch at State-of-the-Art Aseptic Injectable Fill-Finish Facility

Kindeva Drug Delivery (Kindeva), a leading global CDMO, announced two key milestones for its Bridgeton, MO, facility. The site has successfully completed its first registration batch on its groninger high-volume vial line. This achievement showcases the facility’s readiness to meet the growing demand for injectable fill-finish capabilities and marks a crucial step in the company’s expansion.

Michael Kerman on LinkedIn

We're delighted to have Pharmaceutical Commerce Magazine as a sponsor of our #AccessInsightsConference in DC next week! There's still time to join us! Register today: https://lnkd.in/eYB8irsw

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs